All stock lists
Universal Health Services Inc (New York Stock Exchange:UHS)
US · Delayed Price · Currency is USD
Also listed: 0LJL.LHealthcare · Medical - Care Facilities
$193.84-$2.93 (-1.49%)
Market cap
$10.0B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 9, 1981
Website
Insider Score
––Not scored
UHS Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
UHS analyst forecast
UHS analyst consensus
Hold5 ratings
Buy 2 Hold 3 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
UHS 12-month price target
$182.75-5.7% downsideaverage of 4 firms
$201.00High
$156.00Low
Best analysts covering UHS
- TD Cowen67%success rate · +4.4% avg return · 3 calls
- UBS25%success rate · -14.5% avg return · 8 calls
- Barclays17%success rate · -8.6% avg return · 12 calls
- Guggenheim0%success rate · -21.3% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
UHS analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| RBC Capital | Sector Perform | $183.00 | +6.5% | Reiterated | 2026-11-11 | |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-11-02 |
| — | Baird | Neutral | — | — | Reiterated | 2026-10-29 |
| Guggenheim | Buy | $201.00 | +16.7% | Reiterated | 2026-10-29 | |
| Robert W. Baird | — | $156.00 | -9.4% | Price target | 2026-10-29 | |
| — | Leerink Partners | Outperform | — | — | Reiterated | 2026-09-18 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-07-30 |
| Morgan Stanley | Equal Weight | $191.00 | +14.9% | Reiterated | 2026-07-29 | |
| Guggenheim | Buy | $189.00 | +13.7% | Reiterated | 2026-07-29 | |
| — | Cantor Fitzgerald | Neutral | — | — | Reiterated | 2026-07-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-07-28 |
| Guggenheim | Buy | $274.00 | +14.4% | Reiterated | 2026-07-20 | |
| — | Barclays | Equal Weight | — | — | Downgraded | 2026-07-08 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-06-22 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-30 |
| RBC Capital | Sector Perform | $231.00 | +3.3% | Reiterated | 2026-04-29 | |
| Robert W. Baird | — | $204.00 | +25.5% | Price target | 2026-04-29 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-28 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2026-01-07 |
UHS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-25 | $5.92 | $5.88 | $4.50B | $4.49B |
| 2026-04-27 | $5.41 | $5.62 | $4.39B | $4.50B |
| 2026-07-27 | $5.94 | $5.98 | $4.58B | $4.64B |
| 2026-10-27 | $5.19 | $5.22 | $4.71B | $4.73B |
| 2027-02-24Upcoming | $5.63 | — | $4.75B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.